Risk factors for nonadherence to warfarin: results from the IN-RANGE study

被引:98
作者
Platt, Alec B. [1 ,2 ]
Localio, A. Russell [1 ,3 ]
Brensinger, Colleen M. [1 ]
Cruess, Dean G. [4 ]
Christie, Jason D. [1 ,2 ]
Gross, Robert [1 ,2 ,3 ,5 ]
Parker, Catherine S. [6 ]
Price, Maureen [1 ]
Metlay, Joshua P. [1 ,2 ,3 ,5 ]
Cohen, Abigail [1 ]
Newcomb, Craig W. [1 ]
Strom, Brian L. [1 ,2 ,3 ]
Laskin, Mitchell S. [7 ]
Kimmel, Stephen E. [1 ,2 ,5 ]
机构
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA
[4] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA
[5] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA
[6] Beth Israel Deaconess Med Ctr, Dept Internal Med, Boston, MA 02215 USA
[7] Hosp Univ Penn, Dept Pharm Serv, Philadelphia, PA 19104 USA
关键词
medication adherence; MEMS; warfarin; anticoagulation;
D O I
10.1002/pds.1556
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Warfarin is widely used to prevent stroke and venous thromboembolism despite its narrow therapeutic window, Warfarin nonadherence is a substantial problem, but risk factors have not been well elucidated. Methods A prospective cohort study of adults initiating warfarin at two anticoagulation clinics (University and VA-affiliated) was performed to determine factors affecting nonadherence to warfarin. Nonadherence, defined by failure to record a correct pill bottle opening each day, was measured daily via electronic medication event monitoring systems (MEMS) caps. A multivariable explanatory model using logistic regression for longitudinal data was used to identify risk factors for nonadherence. Results One hundred eleven subjects were followed for a median of 137 days. Warfarin nonadherence was common (4787 of 22 425 or 21 % of patient-days observed). Factors independently associated with higher odds of nonadherence included education beyond high school (odds ratio (OR) 1.8 (95%CI 1.2-2.7)), lower Short Form (SF)-36 mental component score (OR 1.4 (1.1-1.6) for each 10 point decrease); and impaired cognition (! 19 points) on the Cognitive Capacity Screening Examination (CCSE) (OR 2.9 (1.7-4.8)). Compared to currently employed subjects, unemployed (OR 0.6 (0.3-1.2)) and retired (OR 0.5 (0.3-0.8)) subjects had somewhat improved adherence; disabled subjects over age 55 had worse adherence (OR 1.8 (1.1-3.1)) than younger disabled subjects (OR 0.8 (0.4-1.5)). Conclusions Poor adherence to warfarin is common and risk factors are related to education level, employment status, mental health functioning, and cognitive impairment. Within the carefully controlled anticoagulation clinic setting, such patient-specific factors may be the basis of future interventions to improve nonadherence. Copyright (C) 2008 John Wiley & Sons. Ltd.
引用
收藏
页码:853 / 860
页数:8
相关论文
共 28 条
[1]   The pharmacology and management of the vitamin K antagonists [J].
Ansell, J ;
Hirsh, J ;
Poller, L ;
Bussey, H ;
Jacobson, A ;
Hylek, E .
CHEST, 2004, 126 (03) :204S-233S
[2]   Determinants of compliance with anticoagulation: A case-control study [J].
Arnsten, JH ;
Gelfand, JM ;
Singer, DE .
AMERICAN JOURNAL OF MEDICINE, 1997, 103 (01) :11-17
[3]   Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy [J].
Choo, PW ;
Rand, CS ;
Inui, TS ;
Lee, MLT ;
Cain, E ;
Cordeiro-Breault, M ;
Canning, C ;
Platt, R .
MEDICAL CARE, 1999, 37 (09) :846-857
[4]   Predictors of medication adherence in inflammatory bowel disease [J].
Ediger, Jason P. ;
Walker, John R. ;
Graff, Lesley ;
Lix, Lisa ;
Clara, Ian ;
Rawsthorne, Patricia ;
Rogala, Linda ;
Miller, Norine ;
McPhail, Cory ;
Deering, Kathleen ;
Bernstein, Charles N. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (07) :1417-1426
[5]   Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy [J].
Gross, R ;
Bilker, WB ;
Friedman, HM ;
Coyne, JC ;
Strom, BL .
AIDS, 2002, 16 (13) :1835-1837
[6]   Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range [J].
Hirsh, J ;
Dalen, JE ;
Anderson, DR ;
Poller, L ;
Bussey, H ;
Ansell, J ;
Deykin, D .
CHEST, 2001, 119 (01) :8S-21S
[7]   RISK-FACTORS FAR INTRACRANIAL HEMORRHAGE IN OUTPATIENTS TAKING WARFARIN [J].
HYLEK, EM ;
SINGER, DE .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (11) :897-902
[8]   SCREENING FOR ORGANIC MENTAL SYNDROMES IN MEDICALLY ILL [J].
JACOBS, JW ;
BERNHARD, MR ;
DELGADO, A ;
STRAIN, JJ .
ANNALS OF INTERNAL MEDICINE, 1977, 86 (01) :40-46
[9]   Warfarin and cytochrome P4502C9 genotype: possible ethnic variation in warfarin sensitivity [J].
Kealey, Canel ;
Chen, Zhen ;
Christie, Jason ;
Thorn, Caroline F. ;
Whitehead, Alexander S. ;
Price, Maureen ;
Samaha, Frederick F. ;
Kimmel, Stephen E. .
PHARMACOGENOMICS, 2007, 8 (03) :217-225
[10]   The influence of patient adherence on anticoagulation control with warfarin - Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study [J].
Kimmel, Stephen E. ;
Chen, Zhen ;
Price, Maureen ;
Parker, Catherine S. ;
Metlay, Joshua P. ;
Christie, Jason D. ;
Brensinger, Colleen M. ;
Newcomb, Craig W. ;
Samaha, Frederick F. ;
Gross, Robert .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (03) :229-235